Every Form 4 that BlackRock Health Sciences Term Trust (BMEZ) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BMEZ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BMEZ filings page.
Liu Xiang, a portfolio manager for BlackRock Health Sciences Term Trust, reported multiple equity-related transactions dated January 30, 2026. The filing shows the exercise of derivative awards into 777.9221 shares of common stock, followed by a same-day sale of those 777.9221 shares at $15.21 per share, leaving no directly held common stock.
The transactions also include an award of 1,026.693 phantom shares at a reference value of $15.21. Each phantom share is the economic equivalent of one share of common stock and is payable in cash, vesting in equal installments on each of the first three anniversaries of the award.
BlackRock Health Sciences Term Trust (BMEZ) portfolio manager Erin H. Xie reported a mix of phantom share awards, exercises, and a stock sale on January 30, 2026. Xie was granted 17,560.4931 phantom shares, each economically equivalent to one common share and payable in cash subject to vesting.
On the same date, Xie exercised previously granted phantom shares into 25,676.2744 common shares, then disposed of all 25,676.2744 common shares in a sale at $15.21 per share, leaving no directly owned common stock after the transactions. The phantom share awards vest in equal installments over three years.
BlackRock Health Sciences Term Trust director reports share sales in Form 4 filing. The director sold 10,294 common shares of BMEZ on 12/18/2025 at a price of $14.98 per share, followed by a sale of 0.422 share on 12/19/2025 at $14.96 per share. After these direct transactions, the director no longer held the shares directly. The filing also reports corresponding transactions in common stock held indirectly by the director's spouse on the same dates and prices, with those indirect holdings also reduced to zero. The report is filed for one reporting person, who serves as a director of the trust, and is signed by an attorney-in-fact.